Sign In
Buy CZMWY
$30.31
+0.0800 (+0.265%)
At Close: Jun 03, 2026
Carl Zeiss Meditec AG (CZMWF) Q3 2024 Earnings Call Transcript
01:43pm, Monday, 12'th Aug 2024
Carl Zeiss Meditec AG (OTCPK:CZMWF) Q3 2024 Results Conference Call August 6, 2024 4:30 AM ET Company Participants Sebastian Frericks - Director of Investor Relations Markus Weber - CEO & Chairman of
Carl Zeiss Meditec: Slightly Better Valuation, Still A Significant Upside
04:50pm, Friday, 17'th May 2024
Carl Zeiss Meditec has underperformed in the medtech field, but its long-term appeal remains intact. The company reported a decline in revenue and margins in the first half of 2023/2024, mainly due to
Carl Zeiss Meditec AG (CZMWF) Q2 2024 Earnings Call Transcript
07:48am, Sunday, 12'th May 2024
Carl Zeiss Meditec AG (OTCPK:CZMWF) Q2 2024 Earnings Conference Call May 8, 2024 4:30 AM ET Company Participants Sebastian Frericks - Head, IR Markus Weber - CEO Justus Wehmer - CFO Conference Call Pa
Carl Zeiss: We've Seen Outperformance, But I See More Upside Potential
02:41am, Friday, 26'th Jan 2024
Carl Zeiss Meditec has seen a significant increase in stock performance, up over 29% in less than 3 months. The company has shown strong top-line growth but a decline in EBIT and EBIT margin. Challeng
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
01:58pm, Friday, 15'th Dec 2023
Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment JENA, Germany , Dec. 15, 2023 /PRNewswire/ -- Carl
Carl Zeiss Meditec: Premiums Are Proven To Be Dicey In This Market
03:32am, Tuesday, 24'th Oct 2023
Carl Zeiss Meditec has seen a decline in its stock price, along with other high-valued companies, due to the commoditization of premium stocks. The company has impressive products, high gross margins,
Carl Zeiss Meditec: One Of The Highest Premiums I'll Accept
05:13am, Tuesday, 08'th Aug 2023
Carl Zeiss Meditech is a subsidiary of Carl Zeiss AG and manufactures tools for eye examination and medical lasers. The company has a strong financial performance with high gross and net margins. Desp
Carl Zeiss Meditec: Buying Opportunity For A Stable Compounding Business
02:19pm, Monday, 07'th Nov 2022
Carl Zeiss Meditec recorded strong order growth of 36% YoY in Q3 FY9/2022 results, highlighting strong underlying demand. Operating margins look stable at 20%, driven by an improving sales mix despite
